4.050
-0.030
(-0.74%)
At close: January 28 at 12:08:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-144,162.000
-144,162.000
-202,464.000
-146,930.000
-84,911.000
Investing Cash Flow
149,845.000
149,845.000
-1,148,383.000
-274,492.000
132,297.000
Financing Cash Flow
-81,496.000
-81,496.000
-1,419.000
-31,098.000
-21,670.000
End Cash Position
330,117.000
330,117.000
403,768.000
1,727,411.000
2,210,504.000
Capital Expenditure
-19,158.000
-19,158.000
-14,401.000
-7,198.000
-38,960.000
Issuance of Capital Stock
--
--
961.000
--
--
Repurchase of Capital Stock
-78,961.000
-78,961.000
--
-28,689.000
-19,601.000
Free Cash Flow
-163,320.000
-163,320.000
-216,865.000
-154,128.000
-123,871.000
12/31/2020 - 8/1/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ABPWW Abpro Holdings, Inc.
0.0500
+42.86%
1228.HK CANBRIDGE-B
0.147
+13.08%
2157.HK Lepu Biopharma Co., Ltd.
2.730
-4.88%
2616.HK CStone Pharmaceuticals
2.340
0.00%
MSCLF Satellos Bioscience Inc.
0.5558
-7.37%
DBV.PA DBV Technologies S.A.
0.8110
-0.73%
PHVS Pharvaris N.V.
17.90
+1.47%
SRZN Surrozen, Inc.
11.82
+5.02%
IKNA Ikena Oncology, Inc.
1.4796
-1.36%
1801.HK INNOVENT BIO
33.050
+0.15%